Bila kanker hati primer disertai dengan asites, penyakit kuning, metastasis jauh, dll., maka disebut kanker hati primer stadium lanjut. Pengobatan kanker hati primer stadium lanjut sulit dilakukan, dan efek pengobatan klinisnya tidak ideal. Pembedahan bukanlah pilihan untuk mengobati kanker hati stadium lanjut karena kanker telah menyebar ke kelenjar getah bening atau organ lain.
If the liver is in good condition (Child-Pugh grade A or B), the doctor will consider treatment with the targeted therapeutic drugs Sorafenib (Nexavar) or Lenvama (Lenvima). Growth can prolong the survival time of patients. If the patient develops drug resistance, the targeted drug repaglinide (Stivarga) or the imunoterapi drug nivolumab (Opdivo) can be used instead.
In addition, keeping an eye on clinical trial information at any time and actively participating in relevant clinical trials such as chemotherapy, radiotherapy, and immunotherapy may also bring opportunities and hope for patients with advanced kanker hati. It is hoped that in the next few years, researchers will make a huge breakthrough in the field of liver cancer diagnosis and treatment.
